Adam focuses his practice on corporate law, financing, and technology transactions in the life sciences and health technology industries. His clients include a wide range of life science and health care companies, as well as venture capital and private equity funds.
Adam has a specific focus on strategic partnering and commercialization for pharmaceutical, biotechnology, and medical device companies. He frequently advises on complex licensing, strategic collaborations, venture capital, mergers and acquisitions, and intellectual property transactions and helps his clients develop, scale, and commercialize their technologies in Canada, the United States, and other countries around the world.
Before law school, Adam attended the Leslie Dan Faculty of Pharmacy at the University of Toronto and is a licensed pharmacist in Ontario.
News & Press
Six Mintz Attorneys Ranked In Chambers Canada
September 28, 2023
Events & Speaking
Doing Life Sciences Deals in 2024 - Licensing, M&A, and More
Hosted by Mintz and the Life Sciences Sector and the Boston Chapter of Licensing Executives Society USA and Canada
Boston
Biotech Licenses in the 2020s – Everything You Need to Know About Cell and Gene Therapy Licenses
Licensing Executives Society Annual Meeting
Chicago, IL
Recognition & Awards
Chambers Canada: Life Sciences: Corporate/Commercial Nationwide, Associates to Watch
Involvement
- Chair, Medical Devices Committee of the Licensing Executives Society (LES)
- Certified Licensing Professional (CLP)
- Member, Ontario College of Pharmacists